The decision to allow a new trial could have  implications for both the companies and families with babies born prematurely.

The FDA would embark on a comprehensive look at the nutrients used in infant formula and increase testing for heavy metals ...

A new Consumer Reports investigation found lead, arsenic, BPA, and PFAS in popular brands. But there are steps you can take ...

We recently published a list of 10 Best Diabetes Stocks To Buy According to Billionaires. In this article, we are going to ...

Infant formula makers Abbott and Reckitt saw their stocks decline Friday after a judge ruled plaintiffs could pursue a new ...

Abbott Laboratories' medical device business is executing well, with double-digit growth in structural heart and diabetes.

Health and Human Services Secretary Robert F. Kennedy Jr. is taking on baby formula products, the latest in his sweeping ...

Reckitt said on Friday a circuit court in the United States had ruled that a new trial could be sought by plaintiffs in a ...

Shares of Abbott Laboratories and Reckitt Benckiser fell Friday after a judge ruled a new trial could be heard involving a case on their infant formula products that had already seen a ruling in their ...

The most recent trading session ended with Abbott (ABT) standing at $130.28, reflecting a -1.79% shift from the previouse trading day's closing. This change lagged the S&P 500's 0.49% gain on the day.

Abbott EVP Lisa Earnhardt's pay increased 19% to $6.6 million as her medical device group's sales grew by 12%.